Literature DB >> 23079302

Delivering better end-of-life care in England: barriers to access for patients with a non-cancer diagnosis.

Rachael Addicott1.   

Abstract

The End of Life Care Strategy (Department of Health, 2008) radically raised the profile of end-of-life care in England, signalling the need for development in planning and delivery, to ensure that individuals are able to exercise genuine choice in how and where they are cared for and die. Research has indicated that there have been continuing difficulties in access to high-quality and appropriate support at the end of life, particularly for patients with a diagnosis other than cancer. This article uses research findings from three case studies of end-of-life care delivery in England to highlight some of the barriers that continue to exist, and understand these challenges in more depth. Access to high-quality and appropriate end-of-life care has been a challenge for all patients nearing the end of life. However, the findings from this research indicate that there are several interrelated reasons why access to end-of-life care services can be more difficult for patients with a non-cancer diagnosis. These issues relate to differences in disease trajectories and subsequent care planning, which are further entrenched by existing funding arrangements.

Entities:  

Mesh:

Year:  2012        PMID: 23079302     DOI: 10.1017/S1744133112000230

Source DB:  PubMed          Journal:  Health Econ Policy Law        ISSN: 1744-1331


  2 in total

1.  Hospitalisation at the end of life among cancer and non-cancer patients in Denmark: a nationwide register-based cohort study.

Authors:  Anne Høy Seemann Vestergaard; Mette Asbjoern Neergaard; Christian Fynbo Christiansen; Henrik Nielsen; Thomas Lyngaa; Kristina Grønborg Laut; Søren Paaske Johnsen
Journal:  BMJ Open       Date:  2020-06-28       Impact factor: 2.692

2.  Intensive care at the end of life in patients dying due to non-cancer chronic diseases versus cancer: a nationwide study in Denmark.

Authors:  Thomas Lyngaa; Christian Fynbo Christiansen; Henrik Nielsen; Mette Asbjørn Neergaard; Anders Bonde Jensen; Kristina Grønborg Laut; Søren Paaske Johnsen
Journal:  Crit Care       Date:  2015-11-24       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.